搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
19 小时
Lilly Alzheimer’s Dosing Tweak Cuts Brain Swelling Risk in Study
Eli Lilly & Co. said that a small change in dosing its Alzheimer’s drug Kisunla cut patients’ rate of brain-swelling side ...
14 小时
Gradual dosing of Lilly Alzheimer's drug cuts brain-swelling risk, study finds
Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...
FiercePharma
15 小时
Modified dosing regimen of Eli Lilly's Alzheimer's drug leads to significant reduction in ...
A small tweak in the dosing regimen of Eli Lilly’s Alzheimer’s disease drug Kisunla has reduced brain swelling of patients in ...
STAT
18 小时
Eli Lilly says modified dosing of its Alzheimer’s drug may be safer
A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among ...
pharmaphorum
3 小时
Lilly touts new Kisunla regimen that reduces side effects
Eli Lilly says a new starting dose regimen for its Alzheimer's disease therapy Kisunla reduces the risk of side effects that ...
50 秒
A Blood Test for Alzheimer’s
These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...
6 天
England’s Drug-Cost Watchdog Rejects Eli Lilly’s Alzheimer’s Drug
Regulator cited significant uncertainties about the drug’s benefits, as well as the high costs to treat its severe side ...
15 小时
Eli Lilly says Donanemab redudced ARIA-E in early Alzheimer’s patients
Eli Lilly (LLY) announced “positive results” from the TRAILBLAZER-ALZ 6 Phase 3b study, showing a reduction in amyloid-related ...
1 天
AbbVie is buying an Alzheimer's drug for more than $1 billion
AbbVie (ABBV) announced Monday that it is buying Aliada Therapeutics for $1.4 billion. The deal includes Aliada’s lead drug ...
Swissinfo
2 小时
Roche Discloses Patient Death in Alzheimer’s Trial
An elderly patient died in a clinical study of Roche Holding AG’s experimental treatment for Alzheimer’s disease, prompting ...
38 分钟
Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth ...
Revenue in Q3 2024 increased 20%, driven by volume growth from Mounjaro and Zepbound, partially offset by $1.42 billion of ...
7 天
Eli Lilly Alzheimer’s Drug Rejected for NHS Use in England
Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈